Screening for prostatacancer--hvad siger evidensen?

Michael Borre, Peter Iversen

    7 Citationer (Scopus)


    A recent Cochrane review of the available randomised evidence for screening for prostate cancer is referred and discussed. The review concludes that there is insufficient evidence to either support or refute the routine use of mass, selective or opportunistic screening compared to no screening in order to reduce prostate cancer mortality. Until ongoing large, randomised screening trials mature and produce results that may prove otherwise, the Danish policy of not recommending PSA-based screening should be upheld.
    Bidragets oversatte titel[Screening for prostate cancer--what does the evidence show?]
    TidsskriftUgeskrift for Laeger
    Udgave nummer20
    Sider (fra-til)1887-8
    Antal sider2
    StatusUdgivet - 14 maj 2007


    Dyk ned i forskningsemnerne om 'Screening for prostatacancer--hvad siger evidensen?'. Sammen danner de et unikt fingeraftryk.